Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Malar J. 2017 Aug 11;16(1):330. doi: 10.1186/s12936-017-1986-6.
The sexual stages (gametocytes) of Plasmodium falciparum do not directly contribute to the pathology of malaria but are essential for transmission of the parasite from the human host to the mosquito. Mature gametocytes circulate in infected human blood for several days and their circulation time has been modelled mathematically from data of previous in vivo studies. This is the first time that longevity of gametocytes is studied experimentally in vitro.
The in vitro longevity of P. falciparum gametocytes of 1 clinical isolate and 2 laboratory strains was assessed by three different methods: microscopy, flow cytometry and reverse transcription quantitative real-time PCR (RT-qPCR). Additionally, the rate of gametocytogenesis of the used P. falciparum strains was compared.
The maximum in vitro lifespan of P. falciparum gametocytes reached almost 2 months (49 days by flow cytometry, 46 days by microscopy, and at least 52 days by RT-qPCR) from the starting day of gametocyte culture to death of last parasite in the tested strains with an average 50% survival rate of 6.5, 2.6 and 3.5 days, respectively. Peak gametocytaemia was observed on average 19 days after initiation of gametocyte culture followed by a steady decline due to natural decay of the parasites. The rate of gametocytogenesis was highest in the NF54 strain.
Plasmodium falciparum mature gametocytes can survive up to 16-32 days (at least 14 days for mature male gametocytes) in vitro in absence of the influence of host factors. This confirms experimentally a previous modelling estimate that used molecular tools for gametocyte detection in treated patients. The survival time might reflect the time the parasite can be transmitted to the mosquito after clearance of asexual parasites. These results underline the importance of efficient transmission blocking agents in the fight against malaria.
疟原虫的有性阶段(配子体)不会直接导致疟疾的病理,但对于寄生虫从人类宿主传播到蚊子至关重要。成熟的配子体在感染的人体血液中循环数天,其循环时间已通过先前的体内研究数据进行了数学建模。这是首次在体外实验中研究配子体的寿命。
通过三种不同的方法评估了 1 株临床分离株和 2 株实验室株的疟原虫配子体的体外寿命:显微镜、流式细胞术和逆转录定量实时 PCR(RT-qPCR)。此外,还比较了所用疟原虫株的配子体生成率。
从配子体培养的起始日期到测试株中最后一个寄生虫死亡,疟原虫配子体的体外最长寿命几乎达到 2 个月(流式细胞术为 49 天,显微镜为 46 天,至少为 52 天),在测试株中平均 50%的存活率分别为 6.5、2.6 和 3.5 天。在启动配子体培养后平均 19 天观察到配子体血症峰值,随后由于寄生虫自然衰减,配子体数量逐渐下降。NF54 株的配子体生成率最高。
在没有宿主因素影响的情况下,疟原虫成熟配子体在体外最多可存活 16-32 天(至少 14 天用于成熟雄性配子体)。这从实验上证实了之前利用分子工具检测治疗后患者配子体的建模估计。存活时间可能反映了寄生虫在清除无性寄生虫后可传播给蚊子的时间。这些结果强调了高效传播阻断剂在抗击疟疾中的重要性。